Harpoon Shareholder Sues For Records On $680M Merck Buy
Law 360 M&A
MARCH 7, 2024
A shareholder of Harpoon Therapeutics Inc. sued in Delaware's Court of Chancery Thursday for corporate documents related to the company's proposed $680 million cash buyout by Merck, saying the proposed deal appears to unfairly "lock in a windfall for select Harpoon investors."
40 
Let's personalize your content